NCT04105231View on ClinicalTrials.gov

Cannabidiol for Treatment of Non-affective Psychosis and Cannabis Use

PHASE2RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Dual Diagnosis
Interventions
DRUG

Cannabidiol

Cannabidiol oral suspension

DRUG

Risperidone

Risperidone, encapsulated tablet.

Trial Locations (1)

2600

RECRUITING

Center for Neuropsychiatric Schizophrenia Research, Glostrup Municipality

All Listed Sponsors
collaborator

Danish Center for Sleep Medicine

OTHER

collaborator

Copenhagen University Hospital, Denmark

OTHER

collaborator

Glostrup University Hospital, Copenhagen

OTHER

collaborator

University of Copenhagen

OTHER

lead

Lone Baandrup

OTHER